Medical Research Scholarship
MRS Nomination form
Medical Research Scholarship nominations come from the members. To give some direction on what is required from members when they nominate a research project a nomination form has been developed. Members are to use this so your nominations can be considered by the NEC at their meeting in February 2026.
Nomination form to be downloaded HERE. Applications will be called for in December 2025.
2024-2025 Funding
Concussion: Making the invisible visible using amplified MRI.
Concussions, often referred to as mild traumatic brain injuries, pose a significant challenge due to the absence of an objective marker for diagnosis. Currently, healthcare professionals rely on subjective assessments and symptom reports to evaluate and manage concussions. However, the lack of a reliable and quantifiable measure makes it difficult to accurately assess the severity of the injury and monitor the process of recovery.
Dr Samantha Holdsworth, has emerged as a leading figure in the field of medical imaging research. During her time at Stanford University, she pioneered the use of amplified MRI (aMRI) as a potential tool for detecting changes in brain motion due to pathology. Furthermore, Dr Holdsworth's groundbreaking work has demonstrated early results in using aMRI to detect subtle alterations in brain motion caused by concussions. With a dedicated team led by Dr Holdsworth, comprising researchers from Mātai Medical Research Institute, University of Auckland, and Stanford University, she is currently at the forefront of an international collaboration aimed at further investigating the application of aMRI in concussion diagnosis.
Using novel methods to quantify brain motion using aMRI, her team is establishing whether aMRI can serve as an objective measure to differentiate between concussed and non-concussed individuals. By analysing intricate patterns of brain motion and identifying subtle abnormalities, aMRI holds the potential to provide healthcare professionals with a reliable and quantifiable marker for diagnosing and managing concussions.
2022-2023 Funding
The recipient for the 2022-2023 period was Dr Angelica Allermo-Fletcher from Wellington Regional Hospital.
Early diagnosis of cerebral palsy in infants with high risk of neurodevelopmental disability. The proposal is to set up a feasibility study to implement the NZ Best Practise Recommendations for Early Diagnosis of CP through a regional hub based in Wellington. They will work out of the Neonatal Intensive care unit at Wellington Regional Hospital.
Dr Allermo-Fletcher addressed the 101st AGM/Conference outlining the proposed project.
An update has been received from Dr Allermo-Fletcher and can be downloaded here. There is also a link for further information here. Dr Allermo-Fletcher continues her work in this area.
2020-2021 Funding
2018- 2019 Funding
This was awarded to Professor Helen Danesh-Meyer as the prIncipal investigator and Dr Jinny Yoon an Optic Nerve Research Fellow at the Department of Opthalmology, University of Auckland who were proposing to research Nailfold Capillary Changes in Glaucoma: Novel Biomarker of Disease Progression. Dr Hannah Kersten was involved later in the project and spoke to members about the research at the 98th AGM in Taupo.
Glaucoma is the leading cause of preventable blindness in NZ affecting 10% of the population over the age of 70. The site of damage in glaucoma is the optic nerve, at the back of the eye. Causes of damage to the optic nerve remain poorly elucidated. It is recognised that elevated eye pressure is an important risk factor for glaucoma. However, approximately one third of glaucoma patients do not have high eye pressure. Furthermore, glaucoma continues to deteriorate despite treatments that aggressively lower eye pressure.
The aim of the research is to see if nailfold vasculature is a biomarker of glaucoma and can be used to predict those patients who will have very aggressive rapidly deteriorating glaucoma.
If they are able to identify a surrogate biomarker that correlates with the deterioration of glaucoma then treatment can be tapered accordingly: that is treat patients who are likley to deteriorate more aggressively and do not over treat patients who are likely to have milder disease - progressing the goal of personalised treatment in glaucoma management.
2016-2017 Funding
Our Medical Research Scholarship funding for 2016-2017 was awarded to Dr Zubkova at Victoria University of Wellington for research into Alzheimers' Disease, for more information visit
http://www.victoria.ac.nz/news/2016/08/promising-alzheimers-research-takes-a-step-forward
2014-2016 Funding
This scholarship was awarded to the Minds for Minds Charitable Trust at the 93rd AGM/Conference for research into autism.
The trust works in partnership with Autism Research Network New Zealand looking to try and help those families who have a child on the autism spectrum. The network aims to bring together scientists, health professionals, education professionals and the community to facilitate understanding and treatment options for autism.
Dr Taylor heads the study looking at the effect microbial 'communities' have on human health. When these 'communities' are in a state of imbalance, there can be negative consequences. Many recent studies have pointed to a potential link between our gut microbes and neurological disorders, including autism. They are using modern molecular biology techniques to investigate the role, if any, played by gut microbes in the autism spectrum disorders.
A cheque for $15,000 was presented to researcher Dr Mike Taylor on behalf of the Minds for Minds Trust by the then National President Jeanette Andrews.
